Study Group: Luminex 100 System Users(?)
Council Members in this Study Group: 14
Request a survey with this Study Group
Leading Experts in this Study Group
John Waugh
Director of System Laboratory Operations
Henry Ford Health System
John Waugh is Director of System Laboratory Operations at Henry Ford Health System in Detroit, the 12th largest US hospital laboratory, research & and academic medical center. Mr. Waugh has expertise in new and emerging clinical and molecular diagnostic systems, including products and services from...
Stan Schofield, MS, MHA,MT(ASCP)Managing Principal
The Compass Group, Scarborough
Stan Schofield, MS, MHA, MT (ASCP), is President of NorDx, a regional laboratory corporation which is part of the Maine Health System. He also serves as a senior member of the health system executive management team. Mr. Schofield is the Managing Principal of the Compass Group, a confederation of 18...
Related Study Groups
GLG NewsSMAnalyses by this Study Group's Leading Experts(?)
* MRSA is a serious problem in the US, particularly with the increasing spread of community acquired strains (caMRSA). * Toxins produced by many caMRSA are rapidly lethal in populations who get soft-tissue infections or sepsis from these organisms (children, elderly). * Nosocomically-acquired MRSAs...
* Another HIV viral load assay in an increasingly crowded market. * Abbott has a reputation for recalls and recalcitrance in its diagnostics arena. 2007 has not been a good year for them. * Not clear this assay provides significant advantages over other assays recently obtaining FDA approval.
* New class of antibiotic with activity against MRSA that has been used in the US to treat sepsis and severe infections. * As or more expensive than other drug regimens for the patient populations indicated. * Resistance to daptomycin has been reported in MRSA and enterococci. * Has a role, but generally...
* Some interesting in vitro data regarding cidal/killing activity of oritavancin, another peptide antibiotic in the same class as vancomycin. * No significant animal models to date. * One study has shown some toxic effects on eukaryotic cells in vitro. * Remains to be determined if this antibiotic...
* Adding a cephalosporin to the armentarium of antibiotics against MRSA remains a big plus. * Await to hear of available methods for in vitro susceptibility testing of Ceftobiprole to guide use of the antibiotic, alone or in combination with other antibiotics.
Most Common Company Types:
- Academic Medical Center/Hospital or Clinic
- Lab, Academic Medical Center
- Academic Institution*
- Laboratory, Independent
- Pharmaceuticals/Biotechnology Research Services
- Professional or Industry Association*
Most Common Job Types:
- Director
- Physician - Attending Physician
- Physician - Department Chair
- Research Scientist
- Professor
- President
- Assistant Professor
- Physician - Director
- Principal
GLG's 750+ Clients Include:
global mutual funds
global banks
private equity firms